NeoTAILOR: ABiomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With Stage II/III ER-positive, HER2-negative Breast Cancer
Clinical trial NCT05837455 · RECRUITING
Trial details
- NCT number
- NCT05837455
- Sponsor
- Washington University School of Medicine
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-30
- Primary completion
- 2027-11-30
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.